26Feb/21
Breaking: Class 1 Innovative Small-molecule BTK-PROTAC Antineoplastic Drugs Approved
On January 26th, the application for the clinical trial of HSK29116 powder declared by Sichuan Haisco Pharmaceutical Co., Ltd. was accepted by the State Food and Drug Administration. HSK29116 is an oralRead More…